Not giving it to 65+ people seems overly cautious. There are zero cases in that group and even just a small delay will mean many dead. This is trading a potential unlikely side effect for a large number of severe Covid cases in high risk groups. Edit: yes I'm aware they have only a dozen or so dead per week but that also translates to hundreds of severe cases, missed elective surgeries, etc. For what would most likel…
The >65 population in Scandinavia is largely vaccinated already, and incidence of new cases is low. So it's a decision that might be questioned, but which would have small real-world consequences even if it turned out to be incorrect in isolation. That part of the decision might just be the combination of uncertainty combined with the public's skepticism towards this particular vaccine. Giving an impression of listen…
80+ population is largely vaccinated. 70+ isn't, and 60+ is barely begun, at least in Sweden.
But most deaths are in 80+, so current situation is that hospital admissions are trending up (because adults are largely unvaccinated), ICU is trending up (because 50+ are unvaccinated) but deaths are trending down (because 80+ are vaccinated).